Resource utility {#S1}
================

We generated this patient-specific iPSC line to develop human cellular disease models of biliary atresia, a type of cholangiopathy possibly resulting from perturbed early development of the biliary system ([@R2]). BA iPSC lines can be used to study molecular mechanisms underlying the disease and to discover contributing environmental factors ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}).

Resource details {#S2}
================

Peripheral blood cells isolated from a 2-year old biliary atresia patient were cultured under an erythroblast expansion condition before reprogramming. Non-integrating episomal plasmids expressing OCT4, SOX2, KLF4, c-MYC and BCL-XL were used to generate iPSCs. Five independent iPSC-like clones were picked and expanded. One iPSC line BA08.1 was expanded and characterized for its identity and stem cell property. When cultured in feeder-free conditions on plates coated with either matrigel or vitronectin, the iPSC line displays typical morphology of human pluripotent stem cells. The iPSC line expresses pluripotency-related transcription factors OCT4 ([Fig. 1A](#F1){ref-type="fig"}) and NANOG ([Fig. 1B](#F1){ref-type="fig"}) as well as cell surface markers TRA-1-60 ([Fig. 1C](#F1){ref-type="fig"}) and SSEA3 ([Fig. 1D](#F1){ref-type="fig"}). Pluripotency of BA08.1 was assessed by *in-vitro* embryoid body formation assay. Cells expressing markers for endoderm (α-feto-protein), mesoderm (smooth muscle actin) and ectoderm (Tuj-1 β III-tubulin) were detected in day-10 embryoid bodies ([Fig. 1E](#F1){ref-type="fig"}). Karyotyping analysis of the cell line demonstrates a normal male karyotype (46,XY) ([Fig. 1F](#F1){ref-type="fig"}). We also examined the presence of episomal plasmid DNA in the established iPSC lines using a pair of PCR primers specific to the EBNA sequence that is common in all three reprogramming plasmids. PCR amplifications of plasmid DNA controls and iPSC genomic DNA show that the level of vector DNA in BA08.1 cell line is below detection limit by passage 11, even though EBNA DNA can be detected at passage 4 ([Fig. 1G](#F1){ref-type="fig"}). To confirm the identity of this iPSC line, DNA profiling was conducted using a short tandem repeat (STR) typing assay that includes 15 STR loci and amelogenin. Data from STR analysis demonstrate a complete match between BA08 iPSC line and fibroblastic cells isolated from the patient (data archived but not shown). The iPSC culture is also shown to be free from mycoplasma contamination by MycoAlert™ mycoplasma detection kit ([Fig. 1H](#F1){ref-type="fig"}).

Materials and methods {#S3}
=====================

Peripheral blood mononuclear cell expansion and reprogramming {#S4}
-------------------------------------------------------------

Mononuclear cells were isolated from patient blood by Ficoll gradient centrifugation and cultured for 10 days in serum-free medium containing SCF, IL-3, EPO and transferrin ([@R1]). At the end of expansion, the cells were transfected with plasmids MOS (expressing OCT4 and SOX2, addgene plasmid \#64120), MMK (expressing c-MYC and KLF4, addgene plasmid \#64121) and GBX (expressing BCL-XL, addgene plasmid \#64123) using 4D Nucleofector (Lonza) ([@R1]). The cells were then cultured in the same erythroblast expansion condition for two days before being plated onto vitronectin-coated (Life Technologies) plate in DMEM medium containing 10% FBS. Essential 8 medium was used to replace the serum-containing medium the next day and was used throughout the reprogramming process and for continued iPSC culture. Colonies with iPSC morphology were picked at day 14 and expanded as previously described ([@R1]).

Immunocytochemistry and flow cytometry {#S5}
--------------------------------------

iPSC colonies grown on matrigel-coated (Corning) plates or EBs attached on gelatin-coated plates were fixed with 4% paraformaldehyde (Sigma) and washed with PBS. Fixed cells were incubated overnight with appropriate primary antibodies at 4 °C for immunocytochemistry. The next day, cells were washed twice with PBS and incubated with appropriate Alexa Flour 555 or 488 conjugated secondary antibodies (Invitrogen) in PBS at room temperature for 45 min followed by PBS wash. Cells were counterstained with DAPI before immunofluorescence analysis. Images were taken using the motorized Nikon Ti-E microscope and NIS-Elements software. Scale bars in [Fig. 1](#F1){ref-type="fig"} represent 100 µm. For SSEA3 flow cytometry analysis, cells were digested by Accutase and washed by PBS. 1 × 10^5^ cells were incubated with Alexa 488-SSEA3 or isotype control antibody for 30 min at 4 °C. After PBS washing, the cells were analysed by a Guava EasyCyte Flow Cytometer (Millipore).

Embryoid body differentiation {#S6}
-----------------------------

EBs were formed using FBS-containing differentiation medium and cultured in suspension for 7 days. The resulting EBs were then plated on gelatin-coated 24-well plates for additional 3 days. The cells were fixed with 4% paraformaldehyde and stained for markers representing the three germ layers ([@R3]).

Karyotype analysis {#S7}
------------------

Karyotyping of BA08.1 cell line at passage 7 was conducted by G-banding at WiCell Cytogenetics Lab (Madison, Wisconsin).

PCR detection of EBNA1 DNA sequence {#S8}
-----------------------------------

Total DNA from cells was isolated using the Quick-DNA™ Miniprep Kit (Zymo Research). Serially diluted reprogramming plasmid MOS were used as positive controls for amplification. 100 ng of total iPSC DNA, positive and negative (H~2~O) controls were amplified for 40 cycles using Phusion DNA polymerase (NEB) and primers specific for EBNA1 ([@R1]).

Mycoplasma testing {#S9}
------------------

Mycoplasma test was performed on antibiotics-free overnight culture medium using the MycoAlert Kit (Lonza) following manufacturer\'s instruction.

STR analysis {#S10}
------------

STR profiling was conducted at Johns Hopkins Genetic Resources Core Facility using PowerPlex 16 HS Kit (Promega). Markers included in the kit are amelogenin, CSF1PO, D13S317, D16S539, D21S11, D5S818, D7S820, THO1, TPOX, vWA, D18S51, D3S1358, FGA, D8S1179, Penta E and Penta D.
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###### 

Characterization and validation.

  Classification                        Test                                   Result                                                                                             Data
  ------------------------------------- -------------------------------------- -------------------------------------------------------------------------------------------------- -------------------------------------------
  Morphology                            Photography                            Normal human pluripotent stem cell morphology                                                      Not shown but available with author
  Phenotype                             Immunocytochemisty                     Staining for expression of pluripotency markers: OCT4, NANOG and TRA-1-60                          [Fig. 1](#F1){ref-type="fig"} panel A-- C
                                        Flow cytometry                         Assess cell surface marker expression: SSEA-3: 91%                                                 [Fig. 1](#F1){ref-type="fig"} panel D
  Genotype                              Karyotype (G-banding) and resolution   46,XY                                                                                              [Fig. 1](#F1){ref-type="fig"} panel F
  Resolution 475-- 525                                                                                                                                                            
  Identity                              Microsatellite PCR (mPCR)              Not performed                                                                                      --
                                        STR analysis                           PowerPlex 16HS (Promega) 16 sites. Match with donor                                                Submitted in archive with journal
  Mutation analysis (IF APPLICABLE)     Sequencing                             --                                                                                                 --
  Southern Blot OR WGS                  --                                     --                                                                                                 
  Microbiology and virology             Mycoplasma                             Mycoplasma testing by luminescence. Negative.                                                      [Fig. 1](#F1){ref-type="fig"} panel H
  Differentiation potential             Embryoid body formation                Expression of genes in embryoid bodies: smooth muscle actin, Tuj-1 β-tubulin and α-feto protein.   [Fig. 1](#F1){ref-type="fig"} panel E
  Donor screening (OPTIONAL)            HIV 1 + 2 hepatitis B, Hepatitis C     --                                                                                                 --
  Genotype additional info (OPTIONAL)   Blood group genotyping                 --                                                                                                 --
  HLA tissue typing                     --                                     --                                                                                                 

###### 

Reagents details.

  Antibodies used for immunocytochemistry/flow-cytometry                                                                                                     
  -------------------------------------------------------- ----------------------------------------------- ------------------------------------------------- ------------------------------------------------------------------
  Pluripotency marker                                      Mouse anti-OCT4                                 1:200                                             Millipore Cat\# MAB4401, RRID:AB_2167852
  Pluripotency marker                                      Mouse anti-NANOG                                1:100                                             BD Pharmingen Cat\# 560109, RRID:AB_1645597
  Pluripotency marker                                      Mouse anti-TRA-1-60                             1:200                                             Millipore Cat\# MAB4360, RRID:AB_11211864
  Pluripotency marker                                      Alexa Fluor 488 anti-human/mouse SSEA-3         1:20                                              BioLegend Cat\# 330306, RRID:AB_1279440
  Differentiation marker                                   Mouse anti-SMA IgG2a                            1:200                                             Sigma-Aldrich Cat\# A5228, RRID:AB_262054
  Differentiation marker                                   Mouse anti-Tuj-1 IgG, Alexa Fluor 488 labeled   1:800                                             Covance Research Products Inc. Cat\# A488-435L, RRID:AB_10143904
  Differentiation marker                                   Rabbit anti-AFP IgG                             1:200                                             Dako Cat\# A0008, RRID:AB_2650473
  Secondary antibody                                       Alexa Fluor 488 goat anti-mouse IgG (H + L)     1:500                                             Invitrogen Cat \#A11001, RRID:AB_2534069
  Secondary antibody                                       Alexa Fluor 555 goat anti-mouse IgM             1:500                                             Invitrogen Cat\# A21426, RRID:AB_2535847
  Secondary antibody                                       AF555 Donkey anti-rabbit IgG                    1:500                                             Thermo Fisher Scientific Cat\# A-31572, RRID:AB_162543
  Secondary antibody                                       AF555 Goat anti-mouse IgG2a                     1:500                                             Thermo Fisher Scientific Cat\# A-21137, RRID:AB_2535776
  Primers                                                                                                                                                    
                                                             Target                                          Forward/reverse primer (5′-- 3′)                
  Episomal Plasmids (qPCR)                                   EBNA-1 sequence in episomal plasmids            TTTAATACGATTGAGGGCGTCT/GGTTTTGAAGGATGCGATTAAG   

###### 

Resource table

  Unique stem cell line identifier        JHUi001-A
  --------------------------------------- ---------------------------------------------------------------------------------------
  Alternative name(s) of stem cell line   BA08.1
  Institution                             Johns Hopkins University, Baltimore, USA
  Contact information of distributor      Yoon-Young Jang, <yjang3@jhmi.edu>
  Type of cell line                       iPSC
  Origin                                  Human
  Additional origin info                  Age: 2 year
                                          Sex: M
  Cell source                             Peripheral blood
  Method of reprogramming                 Integration-free, episomal plasmid transfection
  Genetic modification                    NO
  Type of modification                    N/A
  Associated disease                      Biliary Atresia
  Gene/locus                              N/A
  Method of modification                  N/A
  Name of transgene or resistance         N/A
  Inducible/constitutive system           N/A
  Date archived/stock date                N/A
  Cell line repository/bank               N/A
  Ethical approval                        The Johns Hopkins Medicine Institutional Review Boards (approval number: IRB00083753)
